Evidence map›Paper›PMID 42080441›Full record

ArticleRNA biology2026

PrfH accelerates repair of colicin E3 - damaged translating ribosomes by RtcB2.

Tinashe P Maviza, Nadezhda R Burmistrova, Aleksandr A Grachev, Elizaveta Khisambeeva, Dmitrii I Shiriaev, Anastasiia S Zarechenskaia, Alena Paleskava, Andrey L Konevega, Olga A Dontsova, Petr V Sergiev

Abstract read
In one paragraph

Article in RNA biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tinashe P MavizaCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Nadezhda R BurmistrovaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Aleksandr A GrachevMolecular and Radiation Biophysics Division, Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of NRC "Kurchatov Institute", Gatchina, Russia.
Elizaveta KhisambeevaCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Dmitrii I ShiriaevFaculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Anastasiia S ZarechenskaiaCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Alena PaleskavaMolecular and Radiation Biophysics Division, Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of NRC "Kurchatov Institute", Gatchina, Russia.
Andrey L KonevegaCenter for Integrative Structural Biology, National Research Centre "Kurchatov Institute", Moscow, Russia.
Olga A DontsovaCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Petr V SergievCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Skolkovo, Russia.ORCID 0000-0001-8866-1863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colicin E3 (E3-rRNAse) abolishes protein biosynthesis in bacteria by cleaving 16S rRNA in the decoding centre. The RtcB2-PrfH 16S rRNA repair module prevents cellular death upon exposure to E3-rRNAse in

Indexed as

ColicinsEscherichia coliEscherichia coli ProteinsPeptide Termination FactorsProtein BiosynthesisRibosomesRibosomal ProteinsRNA, Ribosomal, 16SColicinsEscherichia coli ProteinsPeptide Termination FactorsRibosomal Proteinsribosome releasing factorRNA, Ribosomal, 16Speptide hydrolysisRibosomeribosome rescuerRNA cleavagerRNA ligationtranslation

Identifiers

PMID42080441
PMCPMC13166195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.